Regenxbio bags one of its gene therapy vector partners, buying out a struggling Dimension – Endpoints News
Endpoints News |
Regenxbio bags one of its gene therapy vector partners, buying out a struggling Dimension
Endpoints News Gene therapy player Regenxbio $RGNX has struck a deal to buy the struggling Dimension Therapeutics $DMTX after a setback in the clinic earlier this year brutally hammered the biotech's market cap down to only $30 million. Regenxbio has agreed to buy … REGENXBIO to Acquire Dimension Therapeutics |
